EUVIMEDEUVIMED entdecken
Crossref

Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain–Barré syndrome

Hiroshi Kuroda, Kazuo Fujihara, Ichiro Nakashima, Maki Tateyama, Kimihiko Kaneko, Ohito Tano, Susumu Kusunoki, Masashi Aoki

Clinical and Experimental Neuroimmunology · 2013

DOI: 10.1111/cen3.12006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Neuroimmunology, 2013. Verfasst von Hiroshi Kuroda und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guillain–Barré syndrome ( GBS ) is frequently accompanied by dysautonomia, which potentially leads to a fatal outcome. Pregabalin binds to the α2δ subunit of voltage‐gated calcium channels and has been used as a drug for neuropathic pain. We present a 47‐year‐old woman who had GBS with severe dysautonomia and painful dysesthesia, in whom pregabalin promptly attenuated both symptoms. After symptoms of respiratory infection lasting a week, she showed mydriatic pupils, ophthalmoparesis, weakness in four limbs with areflexia, cerebellar ataxia and limb dysesthesia. Even after intravenous immunoglobulin therapy was started, her neurological symptoms deteriorated; furthermore, she developed severe dysautonomia including intractable hypertension, bradycardia–tachycardia syndrome, paroxysmal facial flushing and paroxysmal nausea. However, promptly after the first dose of pregabalin, both dysautonomia and dysesthesia were attenuated, and her circulatory condition became stable. Thereafter, her neurological symptoms gradually improved. The present case report suggests that pregabalin can be effective in treating dysautonomia, as well as painful dysesthesia in GBS .

Zitieren

APA

Kuroda, H., Fujihara, K., Nakashima, I., Tateyama, M., Kaneko, K., Tano, O., Kusunoki, S., & Aoki, M. (2013). Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain–Barré syndrome. Clinical and Experimental Neuroimmunology. https://doi.org/10.1111/cen3.12006

Vancouver

Kuroda H, Fujihara K, Nakashima I, Tateyama M, Kaneko K, Tano O, et al. Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain–Barré syndrome. Clinical and Experimental Neuroimmunology. 2013. doi:10.1111/cen3.12006

BibTeX
@article{Kuroda2013,
  author = {Kuroda, Hiroshi and Fujihara, Kazuo and Nakashima, Ichiro and Tateyama, Maki and Kaneko, Kimihiko and Tano, Ohito and Kusunoki, Susumu and Aoki, Masashi},
  title = {Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain–Barré syndrome},
  journal = {Clinical and Experimental Neuroimmunology},
  year = {2013},
  doi = {10.1111/cen3.12006}
}
Kostenlos starten →